PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

2025-07-03
(Press-News.org) The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the associated factor EMP1 in the progression of resectable pancreatic cancer (PC). The study, conducted by a team of researchers from the University of Chinese Academy of Sciences and Chongqing Medical University, has established a prognostic model that links EMP1 expression with adverse clinical outcomes, particularly among older PC patients.

 

Pancreatic cancer remains a highly aggressive malignancy with limited treatment options, especially in its resectable form. This study highlights how aging, characterized by systemic and microenvironmental changes, significantly contributes to tumor growth and metastasis. The researchers developed an Age-Related Score (ARS) system, integrating bulk RNA-seq and single-cell RNA-seq data, to predict prognosis in postoperative PC patients. A key finding of the study is the identification of EMP1 as a pivotal molecule within this system, significantly correlating with poor survival outcomes.

 

In both in vitro and in vivo experiments, increased EMP1 expression was shown to promote cell proliferation, migration, and invasion by activating the PI3K/AKT signaling pathway. Using cellular trajectory analysis, the study demonstrated that PC cells with high ARS scores and elevated EMP1 levels exhibited enhanced aging and epithelial-mesenchymal transition (EMT) capabilities, indicating a more aggressive tumor phenotype. Furthermore, the EMP1-driven activation of the PI3K/AKT pathway was identified as a major contributor to the oncogenic potential of pancreatic cancer cells.

 

The team’s in vivo studies using subcutaneous, pulmonary metastasis, and orthotopic pancreatic liver metastasis models in mice corroborated these findings. Mice with EMP1 knockdown exhibited reduced tumor volume and metastasis, while EMP1 overexpression led to increased tumor growth and metastatic spread. Importantly, the application of the PI3K/AKT pathway inhibitor LY294002 successfully reversed the oncogenic effects induced by EMP1, suggesting a potential therapeutic avenue.

 

These findings not only establish EMP1 as an independent risk factor for poor prognosis in PC patients but also propose targeted therapy against EMP1 and the PI3K/AKT pathway as a promising strategy to mitigate tumor progression. Future studies focusing on the immune microenvironment and detailed mechanistic pathways are essential to further elucidate EMP1’s role and to develop age-specific anti-cancer interventions.

# # # # #

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

Scopus CiteScore: 8.4

Impact Factor: 9.4

 

# # # # # #

 

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/

Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/

All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).

Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).

Print ISSN: 2352-4820

eISSN: 2352-3042

CN: 50-1221/R

Contact Us: editor@genesndiseases.com

X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )

 

# # # # # #

Reference

Junfeng Zhang, Jianyou Gu, Tao Zhang, Renpei Xia, Jianbo Li, Mingda Tan, Yongjun Yang, Jifeng Xiang, Bin Xie, Rong Tang, Wangge Li, Xianxing Wang, Shixiang Guo, Huaizhi Wang, The role of the aging process and related factor EMP1 in promoting progression of resectable pancreatic cancer, Genes & Diseases, Volume 12, Issue 5, 2025, 101490, https://doi.org/10.1016/j.gendis.2024.101490

 

Funding Information:

Natural Science Foundation of Chongqing, China CSTB2022NSCQ-MSX1339

Natural Science Foundation of Chongqing, China CSTB2022NSCQ-MSX1273

Foundation of Key Laboratory of Tumor Immunology and Pathology (Army Medical University), Ministry of Education 2023jsz910

National Natural Science Foundation of China 82203165

National Natural Science Foundation of China 82072723,

National Natural Science Foundation of China 82103249

Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) 2022MSXM031

Chongqing Technology Innovation and Application Development Special Key Project CSTB2022TIAD-KPX0170

END



ELSE PRESS RELEASES FROM THIS DATE:

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

2025-07-03
  A recent study published in Genes & Diseases reveals a novel role of XPR1 in promoting ovarian cancer growth by regulating autophagy and MHC-I expression. The research, conducted by scientists from Chongqing Medical University, identifies XPR1 as a critical factor influencing the aggressiveness of ovarian cancer through its interaction with LAMP1 and the PI3K/Akt/mTOR signaling pathway. These findings shed light on new therapeutic targets for ovarian cancer, a malignancy known for its poor prognosis and resistance to immune checkpoint inhibitors.   The ...

Flexible, eco-friendly electronic plastic for wearable tech, sensors

2025-07-03
CLEVELAND—Researchers at Case Western Reserve University have developed an environmentally safer type of plastic that can be used for wearable electronics, sensors and other electrical applications. The material, a so-called ferroelectric polymer, is made without fluorine, considered a “forever” chemical that hurts the environment because compounds made with it don’t break down quickly or at all. Although the researchers are still working to improve the material’s electric and elastic properties, the potential is vast for its flexibility of electronic uses and eco-friendly structure. “How this material ...

Can the Large Hadron Collider snap string theory?

2025-07-03
Key takeaways Researchers from Penn and Arizona State University pinpoint a lone five-particle package (a 5-plet) that could upend string theory by detecting it at the Large Hadron Collider. “Ghost” tracks that vanish mid-flight may be the smoking gun physicists are chasing. Early data squeeze the search window, but the next collider runs could make—or break—the case. In physics, there are two great pillars of thought that don’t quite fit together. The Standard Model of particle physics describes all known fundamental particles and three forces: electromagnetism, ...

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

2025-07-03
UNIVERSITY PARK, Pa. — Alexandra Staub, author and professor of architecture in the College of Arts and Architecture’s Stuckeman School at Penn State, examines how architects can better serve society by changing their approach to the building process in her latest book titled “Architecture and Social Sustainability: Understanding the New Paradigm.” Published by Routledge, the book presents examples of “how we can better design for stakeholder agency, serve historically marginalized populations, and further our theoretical thinking about sustainability writ large,” according to the book’s ...

Synthetic DNA nanoparticles for gene therapy

2025-07-03
CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA nanoparticles, which have potential applications in gene therapy. The grant will support Mathur’s work in synthesizing nanoparticles and studying how they behave inside cells in a laboratory. She will use single-cell injections and a microscope to track the nanoparticles and watch what happens to them over time ...

New model to find treatments for an aggressive blood cancer

2025-07-03
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found.   In a paper published in Nature Communications a team of researchers led from the University of Birmingham have studied blood cells from patients with a blood cancer called myelodysplastic syndrome disease (MDS). This disease often develops into a highly aggressive form of Acute Myeloid Leukaemia (AML).   Working with this new model ...

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

2025-07-03
Acute hypoxemic respiratory failure (AHRF) represents one of the most common yet challenging conditions treated in intensive care units (ICUs) worldwide. While the emergence of multiple options for non-invasive respiratory support has revolutionized care in such cases, selecting the optimal approach remains difficult. Now, a special issue from the Journal of Intensive Medicine titled “Non-invasive respiratory support for acute hypoxemic respiratory failure” provides key insights to guide these critical treatment decisions. This collection establishes a robust foundation for understanding the key respiratory support ...

T cells take aim at Chikungunya virus

2025-07-03
LA JOLLA, CA—A new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus trigger the strongest response from the body's T cells.  With this map in hand, researchers are closer to developing Chikungunya vaccines or therapies that harness T cells to strike specific targets, or "epitopes," to halt infection. The new study also offers important clues for understanding why many people experience chronic, severe joint pain for years after clearing the virus. "Now we can see what T cells are seeing patients with chronic disease," says LJI Assistant Professor ...

Gantangqing site in southwest China yields 300,000-year-old wooden tools

2025-07-03
  New discoveries from the Pleistocene-age Gantangqing site in southwestern China reveal a diverse collection of wooden tools dated from ~361,000 to 250,000 years ago, marking the earliest known evidence of complex wooden tool technology in East Asia. The findings reveal that the Middle Pleistocene humans who used these tools crafted the wooden implements not for hunting, but for digging and processing plants. Although early humans have worked with wood for over a million years, wooden artifacts are quite rare in the archaeological ...

Forests can’t keep up: Adaptation will lag behind climate change

2025-07-03
Ecologists are concerned that forest ecosystems will not keep pace with a rapidly changing climate, failing to remain healthy and productive. Before the rapid climate change of the past century, tree populations in the Northern Hemisphere adapted to colder and warmer periods over thousands of years. During onsets of Ice Ages, tree populations migrated south, seeking warmer conditions as global temperatures cooled, their seeds dispersed by winds and carried by animals. When the climate warmed again, tree species adapted by migrating north to more suitable conditions. Mature trees are long-lived, and their populations can’t migrate quickly. Current climate change ...

LAST 30 PRESS RELEASES:

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

T cells take aim at Chikungunya virus

Gantangqing site in southwest China yields 300,000-year-old wooden tools

Forests can’t keep up: Adaptation will lag behind climate change

Sturgeon reintroduction initiative yields promising first-year survival rate

Study: Babies’ poor vision may help organize visual brain pathways

Research reveals Arctic region was permafrost-free when global temperatures were 4.5˚ C higher than today

Novel insights into chromophobe renal cell carcinoma biology and potential therapeutic strategies

A breakthrough in motor safety: AI-powered warning system enhances capability to uncover hidden winding faults

Research teases apart competing transcription organization models

Connect or reject: Extensive rewiring builds binocular vision in the brain

Benefits and risks: informal use of antibiotics to prevent sexually transmitted infections on the rise in key populations in the Netherlands

New molecular tool sheds light on how cancer cells repair telomeres

First large-scale stem cell bank enables worldwide studies on genetic risk for Alzheimer’s disease

[Press-News.org] New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis